Beyond Chemotherapy in ALL: Emerging Bispecific Antibodies, CAR T-cell Therapies, and Evolving Treatment Strategies

Decera Clinical Education Oncology Podcast · Feb 27, 2026 · 38m

In this episode, Dr Ibrahim Aldoss and Dr Bijal Shah discuss how immunotherapy has transformed the treatment landscape of acute lymphoblastic leukemia (ALL), particularly in relapsed/refractory B-cell ALL, including:

CD19-directed CAR T-cell therapies

Next-generation CD19 bispecific antibodies

The evolving role of allogeneic transplant

Presenters:

Ibrahim Aldoss, MD

Associate Professor

Division of Leukemia

Department of Hematology/HCT

City of Hope National Medical Center

Duarte, California

Bijal Shah, MD, MS

Senior Member, Department of Malignant Hematology

Moffitt Cancer Center

Tampa…